Interventional Oncology Market

Interventional Oncology Market by Technology (Ablation (RF, Microwave, Cryoablation), Radiotherapy (EBRT, IBRT, SRT), TACE, Radioembolization), Application (Liver, Lung, Kidney, Prostate), End User (Hospitals, ASCs, Academia) - Global Forecasts to 2022

Report Code: UC 1824 Dec, 2018, by marketsandmarkets.com

The global interventional oncology market is anticipated to grow at a steady rate during the forecast period. The growth of the market are expected to be driven by major factors such as increasing acceptance and demand for minimally invasive cancer surgeries, technological advancements in the field of interventional oncology, and increasing prevalence of cancer cases across globe. Moreover, ongoing modernization of healthcare infrastructure across emerging countries and growing research activities supported by increased public and private funding are expected to offer high growth opportunities for players active in the market.

However, dearth of well-trained oncologists & radiologists across major countries is expected to restrain the optimal demand growth of this market during the forecast period.

As of 2016, Medtronic plc; Boston Scientific Corporation; Medtronic, Plc; Varian Medical Systems, Inc.; Elekta AB are some of the key players present in global interventional oncology market. Over the past three years, these companies adopted new product launches and enhancements, collaborations, agreements, partnerships, and geographical expansions as their key business strategies to ensure their growth in this market.

Scope of the Report

This research report categorizes Interventional Oncology market into the following segments and subsegments:

Interventional Oncology Market, by Technology

  • Tumor Ablation
    • Radiofrequency (RF) Ablation
    • Microwave Ablation
    • Cryoablation
    • Other Technologies
  • Radiotherapy
    • External Beam Radiotherapy
    • Internal Beam Radiotherapy
    • Systemic Radiotherapy
  • Trans-Arterial Chemoembolization (TACE)
  • Radioembolization
  • Microcatheters

Interventional Oncology Market, by Application

  • Liver Cancer
  • Lung Cancer
  • Kidney Cancer
  • Bone Metastasis
  • Prostate Cancer
  • Other Cancers

Interventional Oncology Market, by End User

  • Hospitals, Surgical Centers & Ablation Centers
  • Ambulatory Care Centers
  • Research and Academia

Interventional Oncology Market, by Region

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Table of Contents

1 Introduction
    1.1 Objectives of The Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Geographic Scope
           1.3.3 Years Considered for The Study
    1.4 Currency
    1.5 Research Limitations
    1.6 Major Stakeholders

2 Research Methodology
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Breakdown of Primaries
                    2.1.2.2 Key Data From Primary Sources
                    2.1.2.3 Key Industry Insights
    2.2 Market Size Estimation
           2.2.1 Bottom-Up Approach
           2.2.2 Top-Down Approach
    2.3 Market Breakdown and Data Triangulation
    2.4 Research Assumptions

3 Executive Summary

4 Premium Insights

5 Market Overview
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Major Market Drivers
           5.2.2 Major Market Restraints
           5.2.3 Key Growth Opportunities
           5.2.4 Major Market Challenges

6 Interventional Oncology Market Value Data, By Technology, USD Million (2015-2022)*
    6.1 Introduction
    6.2 Tumor Abalation
           6.2.1 Radiofrequency (RF) Ablation
           6.2.2 Microwave Ablation
           6.2.3 Cryoablation
           6.2.4 Other Ablation Technologies
    6.3 Radiotherapy
           6.3.1 External Beam Radiotherapy
           6.3.2 Internal Beam Radiotherapy
           6.3.3 Systemic Radiotherapy
    6.4 Trans-Arterial Chemoembolization (TACE) 
    6.5 Radioembolization
    6.6 Microcatheters

7 Interventional Oncology Market Value Data, By Application, USD Million (2015-2022)*
    7.1 Introduction
    7.2 Liver Cancer
    7.3 Lung Cancer
    7.4 Kidney Cancer
    7.5 Bone Metastasis 
    7.6 Prostate Cancer
    7.7 Other Cancers

8 Interventional Oncology Market Value Data, By End User, USD Million (2015-2022)*
    8.1 Introduction
    8.2 Hospitals, Surgical & Ablation Centers 
    8.3 Ambulatory Care Centers 
    8.4 Research & Academia

9 Interventional Oncology Market Value Data, By Region, USD Million (2015-2022)
    9.1 Introduction
    9.2 North America
    9.3 Europe
    9.4 Asia-Pacific
    9.5 Rest of The World**

10 Competitive Landscape
     10.1 Overview
     10.2 Vendor Inclusion Criteria
     10.3 Competitive Leadership Mapping
             10.3.1 Visionary Leaders
             10.3.2 Innovators
             10.3.3 Dynamic Differentiators
             10.3.4 Emerging Companies
     10.4 Competitive Benchmarking
             10.4.1 Analysis of Product Portfolio of Major Players in The Radiotherapy Market (25 Players)
             10.4.2 Business Strategies Adopted By Major Players in The Radiotherapy Market (25 Players)
     10.5 Global Market Share Analysis (2016)

11 Company Profiles***
     11.1 Introduction
             11.1.1 Geographic Benchmarking
     11.2 Medtronic, PLC. 
             11.2.1 Business Overview
             11.2.2 Products Offered
             11.2.3 Recent Developments (2014-2017)
     11.3 Boston Scientific Corporation. .
             11.3.1 Business Overview
             11.3.2 Products Offered
             11.3.3 Recent Developments (2014-2017)
     11.4 Varian Medical Systems, Inc. 
             11.4.1 Business Overview
             11.4.2 Products Offered
             11.4.3 Recent Developments (2014-2017)
     11.5 Elekta Ab
             11.5.1 Business Overview
             11.5.2 Products Offered
             11.5.3 Recent Developments (2014-2017)
     11.6 Angiodynamics , Inc.
             11.6.1 Business Overview
             11.6.2 Products Offered
             11.6.3 Recent Developments (2014-2017)
     11.7 Edap Tms S.A.. 
             11.7.1 Business Overview
             11.7.2 Products Offered
             11.7.3 Recent Developments (2014-2017)
     11.8 Healthtronics, Inc
             11.8.1 Business Overview
             11.8.2 Products Offered
             11.8.3 Recent Developments (2014-2017)
     11.9 Neuwave Medical, Inc
             11.9.1 Business Overview
             11.9.2 Products Offered
             11.9.3 Recent Developments (2014-2017)
     11.1 Accuray Incorporated.
             11.10.1 Business Overview
             11.10.2 Products Offered
             11.10.3 Recent Developments (2014-2017)
     11.11 Iba (Ion Beam Applications Sa)
             11.11.1 Business Overview
             11.11.2 Products Offered
             11.11.3 Recent Developments (2014-2017)
     11.12 Nordion, Inc..
             11.12.1 Business Overview
             11.12.2 Products Offered
             11.12.3 Recent Developments (2014-2017)
     11.13 C. R. Bard, Inc.
             11.13.1 Business Overview
             11.13.2 Products Offered
             11.13.3 Recent Developments (2014-2017)
     11.14 Isoray Medical, Inc.
             11.14.1 Business Overview
             11.14.2 Products Offered
             11.14.3 Recent Developments (2014-2017)
     11.15 Raysearch Laboratories.
             11.15.1 Business Overview
             11.15.2 Products Offered
             11.15.3 Recent Developments (2014-2017)
     11.16 Mitsubishi Electric Corporation.
             11.16.1 Business Overview
             11.16.2 Products Offered
             11.16.3 Recent Developments (2014-2017)

12 Appendix
     12.1 Discussion Guide
     12.2 Knowledge Store: Marketsandmarketsí Subscription Portal
     12.3 Introducing RT: Real-Time Market Intelligence
     12.4 Available Customizations
     12.5 Related Reports


Request for detailed methodology, assumptions & how numbers were triangulated.

Our USP is "Customised multi client reports"-so feel free to provide us specific interest in much greater detail..!!
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
UC 1824
Published ON
Dec, 2018
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Interventional Oncology Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved